Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Riboflavin Supplementation to Patients with Multiple Sclerosis does not Improve Disability Status nor is Riboflavin Supplementation Correlated to Homocysteine.
Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis.
Case report: an orofacial pain patient with spots on the brain-multiple sclerosis versus central systemic lupus erythematosus.
[Clinical study of optic neuritis combined with viral hepatitis].
Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis; From the Safety Assessment of Biologic ThERapy (SABER) Study.
[The neurodegenerative process in multiple sclerosis and the possible neuroprotective effect of treatment with Β-interferon 1a (avonex).]
Subject movement during multislice interleaved MR acquisitions: Prevalence and potential effect on MRI-derived brain pathology measurements and multicenter clinical trials of therapeutics for multiple sclerosis.
Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot study.
Treatment with interferon beta for multiple sclerosis.
Designed Glucopeptides Mimetics of Myelin Protein Epitopes As Synthetic Probes for the Detection of Autoantibodies, Biomarkers of Multiple Sclerosis.
Early versus delayed treatment with laquinimod demonstrated significant reduction in risk of disability progression – Results of three-year ALLEGRO study in relapsing-remitting multiple sclerosis
The structure and function of the S1P1 receptor.
[Autonomic nervous system alteration in multiple sclerosis patients with urinary symptoms. Clinical, urodynamic and cardiovascular study].
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results.
A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease.
Neural correlates of alerting and orienting impairment in multiple sclerosis patients.
Effects of intrathecal triamincinolone-acetonide treatment in MS patients with therapy-resistant spasticity.
Patients with multiple sclerosis show increased oxidative stress markers and somatic telomere length shortening.
Alemtuzumab for relapsing-remitting multiple sclerosis.
The harm of ham hocks: Foreign body impaction in long-standing multiple sclerosis.
Reducing falls and improving mobility in multiple sclerosis.
MicroRNA regulation of lymphocyte tolerance and autoimmunity.
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis.
Histone deacetylase activity is required for human oligodendrocyte progenitor differentiation.
No additional copies of HERV-Fc1 in the germ line of multiple sclerosis patients.

Pages